Justin Luebke has officially joined as a technology commercialization manager at the Indiana University Innovation and Commercialization Office, which protects, markets and licenses intellectual property developed at IU so it can be commercialized by industry. “Justin is a great addition to the ICO team, and we are excited to have him aid in our mission… Read more »
Faculty
Working to move IU ideas and innovations to the market
Indiana University researchers continue to turn ideas and innovations from their labs into inventions, patents, new technologies and startups. The IU Innovation and Commercialization Office, whose mission is to transfer IU innovations from lab to market for public benefit and global impact, reported that IU faculty, staff and student researchers disclosed 144 inventions to the… Read more »
IU researchers developing RealCV app to translate COVID-19’s impact on employees, value of ‘invisible work’
Within months of the start of the COVID-19 pandemic, it became clear that the social and physical impacts of the pandemic varied dramatically across demographics: the elderly and African Americans suffered higher mortality rates, while women—and particularly mothers of young children—bore the impact of school and day care closures. Furthermore, the pandemic exacerbated issues in… Read more »
IU researchers’ quantifiable soft tissue manipulation device moves closer to helping patients
New technology aims to revolutionize the orthopedic manual therapy industry A new device that would allow physical therapists to monitor the level of pressure they apply to the soft tissue of patients seeking greater mobility and pain relief, developed by Indiana University researchers, is one step closer to the healthcare market. Health Smart Technologies, a… Read more »
Patents awarded to five IU innovations
Five Indiana University researchers have received patents from the U.S. Patent and Trademark Office for cutting-edge technologies and other innovations that they aim to move to market. Below is information about each of the patents. Patent issued to IU innovation that tests cell response to biochemical agents: The U.S. Patent and Trademark Office has issued… Read more »
IU hosts Midwest consortium seeking to advance materials science innovations
Indiana University recently hosted the Midwest Material Innovation Consortium (MMIC) for a two-day meeting aimed at discussing industry news, trends and opportunities within the material science industry. The event, which took place last month, was organized by IU’s Office of Business Partnerships, together with the IU Innovation and Commercialization Office (ICO) and IU Ventures, IU’s… Read more »
IU researcher develops method for engineering disease resistance in plants
Crop diseases caused by pathogens, viruses and fungi are very costly and can result in significant yield losses for farmers. Roger Innes, Distinguished Professor of biology at Indiana University Bloomington’s College of Arts and Sciences, has developed a method to enhance the immune system of plants to detect harmful pathogens in hopes of preventing these… Read more »
Winners of IU Life Sciences to Healthcare Solutions Pitch Competition announced
Two Indiana University faculty-led teams were selected as winners of the inaugural IU Life Sciences to Healthcare Solutions Pitch Competition, hosted by IU Research and the IU Innovation and Commercialization Office. A future reality portal that enhances addiction recovery won first place, while an instrument that assesses corneal sensation in patients won second place. “This… Read more »
IU expands partnership with NSWC Crane to advance national security innovation
Indiana University and Naval Surface Warfare Center, Crane Division, have announced an expansion of their partnership to effectively leverage IU’s educational and research assets to support the nation’s strategic defense initiatives and advance and accelerate innovative solutions to national security challenges. At a ceremony Monday afternoon, April 24, at IU’s Luddy School of Informatics, Computing… Read more »
IU School of Medicine researcher determines PRMT5 inhibitors can help treat pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fourth deadliest cancer and has a five-year survival rate of only 10 percent. PDAC, which accounts for more than 90 percent of pancreatic cancer cases, is known to be resistant to most therapeutic agents, and often the diagnosis is late in disease progression as symptoms are difficult to identify…. Read more »